Sanofi to cut US price of its most-prescribed insulin by 78%
French drug maker will also extend $35 out-of-pocket pricing program to patients with commercial insurance
French drug maker will also extend $35 out-of-pocket pricing program to patients with commercial insurance
0 Comments
Recommended Comments
There are no comments to display.
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.